Company Monitoring Page for AbbVie

latest headlines for company on cafepharma

AbbVie Profit Beats Estimates as Sales of Humira Increase
Bloomberg
Fri, 10/25/13 - 09:39 am
Tags:
earnings, AbbVie
Analyzing AbbVie Ahead of Its Third-Quarter Earnings
Motley Fool
Wed, 10/23/13 - 11:39 am
Tags:
AbbVie, earnings
The 3 Best-Selling Drugs in the World
Motley Fool
Mon, 10/21/13 - 08:24 am
Tags:
AbbVie, Humira, Remicade, JNJ, GSK, Advair
3 Pipeline Drugs That Could Have a Dramatic Impact on Parkinson's Disease by 2020
Motley Fool
Thu, 10/17/13 - 08:24 am
Tags:
Parkinson's Disease, pimavanserin, Acadia, Duodopa, AbbVie, LCIG, AFQ056, Novartis
Knockoff Lust: AbbVie's $9 Billion-A-Year Humira
Seeking Alpha
Wed, 10/9/13 - 08:25 am
Tags:
AbbVie, Humira, JNJ, Amgen, rheumatoid arthritis
Teva's First-To-File Track Record Best Among Peers
Seeking Alpha
Mon, 10/7/13 - 07:28 pm
Tags:
Teva, AbbVie
Why AbbVie's Global Alliance With Galapagos Is Good News for Investors
Motley Fool
Fri, 10/4/13 - 11:15 am
Tags:
AbbVie, Galapagos, cystic fibrosis
How AbbVie Plans to Survive After Humira
Motley Fool
Fri, 09/27/13 - 08:20 am
Tags:
AbbVie, Humira, Ablynx, ALX-0061
Insiders Are Selling Biogen Idec
Seeking Alpha
Tue, 09/24/13 - 05:57 pm
Tags:
Biogen Idec, AbbVie, Amgen, Bristol-Myers Squibb, JNJ, Merck, Pfizer, Cephalon
AbbVie and Galapagos enter into alliance to develop cystic fibrosis therapies
The Fly on the Wall
Tue, 09/24/13 - 10:17 am
Tags:
AbbVie, Galapgos, cystic fibrosis
Ablynx Rises on Drug Licensing Deal With AbbVie
Bloomberg
Mon, 09/23/13 - 09:17 am
Tags:
Ablynx, AbbVie, ALX-0061, rheumatoid arthritis
3 Humongous Health-Care Stocks This Week
Motley Fool
Sun, 09/22/13 - 11:08 am
Tags:
Omeros, Enanta, AbbVie
3 Companies Racing to Transform Hepatitis-C Treatment
Motley Fool
Thu, 09/19/13 - 02:58 am
Tags:
hepatitis C, Gilead, sofosbuvir, AbbVie, Bristol-Myers Squibb, daclatasvir, asunaprevir, BMS-791325
Top 10 rheumatoid arthritis drugs 2013
Fierce Pharma
Wed, 09/18/13 - 10:27 am
Tags:
rheumatoid arthritis, Humira, AbbVie, Enbrel, Amgen, Remicade, Janssen, Celebrex, Pfizer, Bristol-Myers Squibb, Orencia, Cimza, UCB, Simponi, JNJ, Arthrotec, Vimovo, AstraZeneca, Kineret
[video]Patent Expirations AbbVie Investors Need to Watch
Motley Fool
Tue, 09/17/13 - 11:49 am
Tags:
AbbVie, Humira, patents, patent expirations
Celgene: FDA Approvals Shining The Biopharma Stock
Seeking Alpha
Mon, 09/16/13 - 11:48 am
Tags:
Celgene, FDA, Bristol-Myers Squibb, AbbVie, JNJ, Eli Lilly, Revlimid, Abraxane
AbbVie Has Excellent Management Efficiency, But Is It A Buy?
Seeking Alpha
Fri, 09/13/13 - 08:36 am
Tags:
AbbVie, Neurocrine, Abbott Labs
Is Seattle Genetics an Acquisition Target?
Motley Fool
Tue, 09/10/13 - 10:26 am
Tags:
M&A, Seattle Genetics, Adcetris, Bayer, AbbVie, Genentech
[video]What Are the Main Threats to AbbVie's Humira?
Motley Fool
Mon, 09/9/13 - 05:15 pm
Tags:
AbbVie, Humira, Pfizer, Xeljanz
Understanding the Massive Market Potential of Monoclonal Antibodies
Motley Fool
Wed, 08/28/13 - 04:53 pm
Tags:
monoclonal antibodies, Roche, Herceptin, Rituxan, Avastin, GSK, Amgen, Eli Lilly, Bristol-Myers Squibb, Seattle Genetics, Adcetris, Kadcyla, bapineuzumab, Elan, JNJ, Pfizer, necitumumab, AbbVie, Humira

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.